Le Lézard
Classified in: Science and technology, Business
Subjects: AWD, CON, JVN

BAE Systems' joint venture Promoveo Solutions awarded Multiple Award Schedule contract to provide IT services to federal, state, and local governments


MCLEAN, Va., Sept. 20, 2023 /PRNewswire/ -- Promoveo Solutions JV LLC, a BAE Systems and Purisolve, Inc. joint venture (JV), has been awarded a contract on the U.S. General Services Administration's (GSA) Multiple Award Schedule (MAS). Under a five-year contract, Promoveo Solutions will provide a broad array of IT services to federal, state, and local governments.

"Promoveo Solutions aims to serve federal agencies through emerging technologies and innovation, which firmly aligns with BAE Systems' mission to protect those who protect us," said David Reynolds, deputy general manager of BAE Systems' Intelligence Solutions business. "We are excited to offer forward-thinking IT solutions and services under this first contract award."

"This award marks a key step for Promoveo Solutions to provide a wide variety of products and services through streamlined procedures to increase acquisition speed and flexible contracting to the marketplace," said Wallace Jones, President, Purisolve, Inc.

Atlanta-based Promoveo Solutions is an outgrowth of the U.S. Small Business Administration-approved mentor-protégé agreement between BAE Systems and Purisolve, Inc., and combines the experience and expertise of the two companies. The JV was formed to pursue long-term contracts to provide IT services and access to commercial products, services, and solutions to federal, state, and local government.

Learn more about Promoveo Solutions here.

For more information, please contact:
Rob Leonard, BAE Systems
Mobile: 667-314-5934
[email protected]

www.baesystems.com/US
@BAESystemsInc

SOURCE BAE Systems, Inc.


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: